Home » Topics » Regulatory

Regulatory
RSS

Ziprasidone pharmaceutical formulations with good solubility properties

Nov. 30, 2000

FDA approves Lovenox for seventh indication

Nov. 22, 2000

FDA approves Boehringer Ingelheim's Micardis HCT

Nov. 21, 2000

New Tamiflu indication for prevention of influenza approved by FDA

Nov. 21, 2000

E.C. approves Roche's CellCept for prevention of liver transplant rejection

Nov. 20, 2000

Steroid-free eczema treatment recommended for FDA approval

Nov. 17, 2000

Lilly's Zyprexa approved by FDA for extended schizophrenia indication

Nov. 15, 2000

Abbott submits Biaxin XL sNDA for CAP

Nov. 14, 2000

Pariet receives E.U. approval for H. pylori eradication in peptic ulcer disease

Nov. 14, 2000

Astelin Nasal Spray approved in U.S. for treatment of nonallergic vasomotor rhinitis

Nov. 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...